Study shows CoronaVac to have high seroconversion rate after 40 days
Researchers from the Federal University of Paraná, Brazil, looked into the seroconversion rate after vaccination with the CoronaVac. Using immunoassays, they measured the immunoglobulins (IgG) for anti-nucleocapsid protein (anti-N) antibodies and anti-spike-1 (anti-S1) protein antibodies.
Nelson Antoine Shutterstock Ramya Dwivedi University Of Paran Coronavac Sinovac Life Sciences Clinical Laboratory Sinovac Life Sciences
Source: news-medical.net